A phase 3 trial shows that once-weekly semaglutide significantly improves liver histology in patients with metabolic ...

Wegovy (semaglutide) could offer a new option to treat severe liver disease based on new clinical trial evidence. The GLP-1 ...

Animal rescuers were desperately seeking assistance Monday after nearly 70 cats, including newborn kittens, were found in a ...

A Wild West weekend at Texas Motor Speedway for the three NASCAR national series ended with three overtime finishes. From the ...

A new study reveals that semaglutide, a common diabetes medication, may effectively treat fatty liver disease, offering hope ...

The Laval Rocket returned to a packed Place Bell looking to apply the broom to the Cleveland Monsters in the North Division ...

Key outcomes of all-cause mortality and portal hypertension complications are improved with SGLT2inhibitors, new research ...

Miní, a wild-born female jaguar, takes an unbelievable journey from the Iberá Wetlands to the Gran Chaco forest to revive a ...

The Tigers (22-13) took three of four from the Angels and head into Monday’s off-day with the AL's best record.

Results showed that 62.9% of patients on Ozempic saw a reduction in liver inflammation, compared to 34.3% on placebo.

Semaglutide, the blockbuster drug better known by brand names like Ozempic and Wegovy, has now shown significant promise in ...

How a commonly “silent disease” is driving urgency and novelty in the liver disease treatment paradigm and what can we hope for.